Supuran CT |
Nanoparticles for controlled release of anti-biofilm agents WO2014130994 (A1): a patent evaluation. |
2015 |
Expert Opin Ther Pat |
pmid:26028186
|
Brilhante RS et al. |
Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol. |
2015 |
J. Med. Microbiol. |
pmid:25657300
|
Leonhardt I et al. |
The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity. |
2015 |
MBio |
pmid:25784697
|
Horev B et al. |
pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. |
2015 |
ACS Nano |
pmid:25661192
|
De Loof A |
The essence of female-male physiological dimorphism: differential Ca2+-homeostasis enabled by the interplay between farnesol-like endogenous sesquiterpenoids and sex-steroids? The Calcigender paradigm. |
2015 |
Gen. Comp. Endocrinol. |
pmid:25540913
|
Léger T et al. |
The metacaspase (Mca1p) has a dual role in farnesol-induced apoptosis in Candida albicans. |
2015 |
Mol. Cell Proteomics |
pmid:25348831
|
Katragkou A et al. |
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. |
2015 |
J. Antimicrob. Chemother. |
pmid:25288679
|
Scheman A et al. |
European Directive fragrances in natural products. |
2014 Mar-Apr |
Dermatitis |
pmid:24603515
|
Chen M et al. |
Use of synthetic isoprenoids to target protein prenylation and Rho GTPases in breast cancer invasion. |
2014 |
PLoS ONE |
pmid:24587105
|
Ronderos DS et al. |
Farnesol-detecting olfactory neurons in Drosophila. |
2014 |
J. Neurosci. |
pmid:24623773
|